A new machine learning algorithm devised by scientists at the University of California San Francisco could help doctors diagnose multiple sclerosis (MS) earlier, by analysing healthcare records and...
Famprya (fampridine) is set to be rejected by The National Institute for Health and Care Excellence (NICE) in England for use on the NHS for people with multiple sclerosis (MS). NICE will recommend...
Sunshine may protect children and young adults from multiple sclerosis (MS) a new study has found. Researchers believe the vitamin D made in the body after exposure to sunlight is the key, and it...
From tomorrow people with multiple sclerosis (MS) who live in the UK and have Covid-19 will be able to receive one of two new treatments that are only currently available for people in hospital....
Taking melatonin has been shown to increase sleep quality in people with multiple sclerosis (MS), a new study has found.
Melatonin is a hormone that is made in the body and it regulates our sleep-...
Treadmill walking exercise training could help manage THE cognitive effects of multiple sclerosis (MS) according to a new study published in Contemporary Clinical Trials.
The single-blind randomised...
People with multiple sclerosis (MS) may find it more difficult to recognise emotions in other people, and experience more intense emotions than those without the condition, a new study has found.
It...
Exposure to the cold may stop and even undo demyelination caused by multiple sclerosis (MS), a new mouse-model study from the University of Geneva suggests.
Scientists induced an MS-like condition in...
Never drinking alcohol increases your risk of developing multiple sclerosis (MS), a new study has found, especially if you smoke or used to smoke.
Previous studies have found that alcohol decreases...
Ponvory (ponesimod) has been approved for use on the NHS in Scotland by the Scottish Medicines Consortium (SMC) for relapsing remitting multiple sclerosis (MS).
Ponvory is taken daily in tablet form...
